LY2584702 tosylate is primarily investigated for its potential therapeutic applications in cancer treatment. It functions as a selective inhibitor of p70S6 kinase, a key enzyme in the mTOR signaling pathway, which plays a critical role in cell growth, proliferation, and survival. By inhibiting this pathway, it aims to suppress tumor growth and progression in various cancers. Preclinical studies have shown promise in reducing tumor size and inhibiting cancer cell proliferation, particularly in solid tumors. It is being explored in combination with other anticancer therapies to enhance efficacy and overcome resistance. Ongoing research focuses on its potential in personalized medicine, targeting cancers with dysregulated mTOR signaling.